1. Mariana Karamanou et al., “From Miasmas to Germs: A Historical Approach to Theories of Infectious Disease Transmission,” Le Infezioni in Medicina 20, no. 1 (март 2012): 58–62, https://pubmed.ncbi.nlm.nih.gov/22475662/.
2. Seun Ayoade, “Thalassemias Validate Germ Terrain Duality of Malaria,” Health Science Journal (2017), doi: 10.21767/1791809X.1000512.
3. Ashutosh K. Mangalam, Meeta Yadav, and Rajwardhan Yadav, “The Emerging World of Microbiome in Autoimmune Disorders: Opportunities and Challenges,” Indian Journal of Rheumatology 16, no. 1 (март 2021): 57–72, doi: 10.4103/injr.injr_210_20.
4. Chiara Bellocchi and Elizabeth R. Volkmann, “Update on the Gastrointestinal Microbiome in Systemic Sclerosis,” Current Rheumatology Reports 20, no. 8 (25 июня 2018): 49, doi: 10.4103 /injr.injr_210_20.
5. Mangalam, “The Emerging World,” 57–72.
6. Bilal Ahmad Paray et al., “Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State,” International Journal of Molecular Sciences 21, no. 24 (декабрь 2020): 9770, doi: 10.3390/ijms21249770.
7. Alexandr Parlesak et al., “Increased Intestinal Permeability to Macromolecules and Endotoxemia in Patients with Chronic Alcohol Abuse in Different Stages of AlcoholInduced Liver Disease,” Journal of Hepatology 32, no. 5 (май 2000): 742–747, doi: 10.1016/s0168 8278(00)80242-1.
8. Peter C. Konturek, Tomasz Brzozowski, and Stanislaw J. Konturek, “Stress and the Gut: Pathophysiology, Clinical Consequences, Diagnostic Approach and Treatment Options,” Journal of Physiology and Pharmacology 62, no. 6 (декабрь 2011): 591–599, https://pubmed.ncbi.nlm.nih.gov/22314561/.
9. Qinghui Mu et al., “Leaky Gut as a Danger Signal for Autoimmune Diseases,” Frontiers in Immunology 8 (2017): 598, doi: 10.3389/fimmu.2017.00598.
10. Maisa C. Takenaka and Francisco J. Quintana, “Tolerogenic Dendritic Cells,” Seminars in Immunopathology 39, no. 2 (февраль 2017): 113–120, doi: 10.1007/s002810160587-8.
11. Andrew T. Gewirtz and James L. Madara, “Periscope, Up! Monitoring Microbes in the Intestine,” Nature Immunology 2 (апрель 2001): 288–290, doi: 10.1038/86292.
12. Guy C. Brown, “The Endotoxin Hypothesis of Neurodegeneration,” Journal of Neuroinflammation 16, no. 180 (13 сентября 2019), doi: 10.1186/s129740191564-7.
13. Brown, “The Endotoxin Hypothesis.”
14. MarieCaroline Michalski et al., “Dietary Lipid Emulsions and Endotoxemia,” Lipid Consumption and Functionality: New Perspectives 23, no. 3 (октябрь 2016): D306, doi: 10.1051 /OCL/2016009.
15. Rui Lin et al., “Abnormal Intestinal Permeability and Microbiota in Patients with Autoimmune Hepatitis,” International Journal of Clinical and Experimental Pathology 8, no. 5 (1 мая 2015): 5153–5160, https://pubmed.ncbi.nlm.nih.gov/26191211/.
16. Nobuo Fuke et al., “Regulation of Gut Microbes and Metabolic Endotoxemia with Dietary Factors,” Nutrients 11, no. 10 (23 сентября 2019): 2277, doi: 10.3390/nu11102277.
17. Jill A. Parnell, Teja Klancic, and Raylene A. Reimer, “Oligofructose Decreases Serum Lipopolysaccharide and Plasminogen Activator Inhibitor-1 in Adults with Overweight/Obesity,” Obesity 25, no. 3 (март 2017): 510–513, doi: 10.1002/oby.21763.
18. Bruce R. Stevens et al., “Increased Human Intestinal Barrier Permeability Plasma Biomarkers Zonulin and FABP2 Correlated with Plasma LPS and Altered Gut Microbiome in Anxiety or Depression,” 1555–1557, doi: 10.1136/gutjnl2017314759.
19. Michael Berk et al., “So Depression Is an Inflammatory Disease, But Where Does the Inflammation Come From?”, BMC Medicine 11, no. 200 (12 сентября 2013), https://bmcmedicine.biomedcentral.com/articles/10.1186/17417015-11-200.
20. Alison C. Bested, Alan C. Logan, and Eva M. Selhub, “Intestinal Microbiota, Probiotics and Mental Health: From Metchnikoff to Modern Advances: Part II–Contemporary Contextual Research,” Gut Pathogens 5, no. 1 (14 марта 2013): 3, doi: 10.1186/17417015-11-200.
21. Michalski, “Dietary Lipid Emulsions,” D306.
22. Patty W. SiriTarino et al., “MetaAnalysis of Prospective Cohort Studies Evaluating the Association of Saturated Fat with Cardiovascular Disease,” American Journal of Clinical Nutrition 91, no. 3 (март 2010): 535–546, doi: 10.3945/ajcn.2009.27725.
23. Rajiv Chowdhury et al., “Association of Dietary, Circulating, and Supplement Fatty Acids with Coronary Risk: A Systematic Review and Metaanalysis,” Annals of Internal Medicine 160, no. 6 (18 марта 2014): 398–406, doi: 10.7326/M131788.
24. L. A. Waddell et al., “The Zoonotic Potential of Mycobacterium Avium Ssp. Paratuberculosis: A Systematic Review and MetaAnalyses of the Evidence,” Epidemiol Infect 143, no. 15, (2015): 3135–57, doi: 10.1017/S095026881500076X.
25. S. Masala et al., “Antibodies Recognizing Mycobacterium Avium Paratuberculosis Epitopes Crossreact with the Betacell Antigen Znt8 in Sardinian Type 1 Diabetic Patients,” PLoS One 6(10), (2011): e26931, doi: 10.1371/journal.pone.0026931.
26. Raja Atreya et al., “Facts, Myths and Hypotheses on the Zoonotic Nature of Mycobacterium Avium Subspecies Paratuberculosis,” International Journal of Medical Microbiology 304, (2014): 858–867, doi: 10.1016/j.ijmm.2014.07.006.
27. Atreya et al., “Facts, Myths and Hypotheses,” 858–867.
28. Martin Feller et al., “Mycobacterium Avium Subspecies Paratuberculosis and Crohn’s Dis-ease: A Systematic Review and Metaanalysis,” Lancet Infect Dis 7, no. 9 (2007): 607–13, doi: 10.1016/S14733099(07)70211-6.
29. John Aitken et al., “A Mycobacterium Species for Crohn’s Disease?”, Pathology 53, no. 7 (2021): 818–823, doi: 10.1016/j.pathol.2021.03.003.
30. Waddell et al., “The Zoonotic Potential,” 3135–3157.
31. Guanxiang Liang and Frederic D. Bushman, “The Human Virome: Assembly, Composition and Host Interactions,” Nature Reviews Microbiology 19 (30 марта 2021): 514–527, doi: 10.1038/s4157902100536-5.
32. Andrey N. Shkoporov and Colin Hill, “Bacteriophages of the Human Gut: The ‘Known Unknown’ of the Microbiome,” Cell Host & Microbe 25, no. 2 (13 февраля 2019): 195–209, doi: 10.1016/j.chom.2019.01.017.
33. Guoyan Zhao et al., “Intestinal Virome Changes Precede Autoimmunity in Type I DiabetesSusceptible Children,” Proceedings of the National Academy of Sciences of the United States of America 114, no. 30 (25 июля 2017): E6166–E6175, doi: 10.1073/pnas.1706359114.
34. Katri Lindfors et al., “Metagenomics of the Faecal Virome Indicate a Cumulative Effect of Enterovirus and Gluten Amount on the Risk of Coeliac Disease Autoimmunity in Genetically At-Risk Children: The TEDDY Study,” Gut 69, no. 8 (август 2020): 1416–1422, doi: 10.1136 /gutjnl2019319809.
35. Melissa A. Fernandes et al., “Enteric Virome and Bacterial Microbiota in Children with Ulcerative Colitis and Crohn’s Disease,” Journal of Pediatric Gastroenterology and Nutrition 68, no. 1 (январь 2019): 30–36, doi: 10.1097/MPG.0000000000002140.
36. Adam G. Clooney et al., “WholeVirome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease,” Cell Host & Microbe 26, no. 6 (11 декабря 2019): 764–778.e5, doi: 10.1016/j.chom.2019.10.009.
37. Tao Zuo et al., “Gut Mucosal Virome Alterations in Ulcerative Colitis,” Gut 68, no. 7 (июль 2019): 1169–1179, doi: 10.1136/gutjnl2018318131.
38. John B. Harley et al., “Transcription Factors Operate across Disease Loci, with EBNA2 Implicated in Autoimmunity,” Nature Genetics 50, no. 5 (май 2018): 699–707, doi: 10.1038/s415880180102-3.
39. Anette Holck Draborg, Karen Duus, and Gunnar Houen, “EpsteinBarr Virus in Systemic Autoimmune Diseases,” Systemic Autoimmune Diseases 535738 (24 августа 2013), doi: 10.1155/2013/535738.
40. Draborg, “EpsteinBarr Virus.”
41. Draborg, “EpsteinBarr Virus.”
42. Shotaro Masuoka et al., “EpsteinBarr Virus Infection and Variants of EpsteinBarr Nuclear Antigen-1 in Synovial Tissues of Rheumatoid Arthritis,” PLoS One 13, no. 12 (11 декабря 2018): e0208957, doi: 10.1371/journal.pone.0208957.
43. Amit Bar-Or et al., “EpsteinBarr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies,” Trends in Molecular Medicine 26, no. 3 (март 2020): 296–310, doi: 10.1016/j.molmed.2019.11.003.
44. Bar-Or, “EpsteinBarr Virus,” 296–310.
45. Alexander G. Gabibov, “Combinatorial Antibody Library from Multiple Sclerosis Patients Reveals Antibodies that CrossReact with Myelin Basic Protein and EBV Antigen,” The FASEB Journal 25, no. 12 (декабрь 2011): 4211–4221, doi: 10.1096/fj.11-190769.
46. “EpsteinBarr Virus and Infectious Mononucleosis: Laboratory Testing,” Centers for Disease Control and Prevention, https://www.cdc.gov/epsteinbarr/laboratorytesting.html.
47. Lin Zhang et al., “The Role of Gut Mycobiome in Health and Diseases,” Therapeutic Advances in Gastroenterology 2021, no. 14 (23 сентября 2021), doi: 10.1177/17562848211047130.
48. Lin Zhang et al., “The Role of Gut Mycobiome in Health and Diseases,” Therapeutic Advances in Gastroenterology 2021, no. 14 (23 сентября 2021), doi: 10.1177/17562848211047130.
49. Yu Gu et al., “The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome,” Frontiers in Microbiology 10 (21 августа 2019): 1894, doi: 10.3389/fmicb.2019.01894.
50. Helen Tremlett et al., “The Gut Microbiome in Human Neurological Disease: A Review,” Annals of Neurology 81, no. 3 (март 2017): 369–382, doi: 10.1002/ana.24901.
51. Julián BenitoLeón, “Association Between Multiple Sclerosis and Candida Species: Evidence from a CaseControl Study,” European Journal of Clinical Microbiology & Infectious Diseases